Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hitoshi Hayasaka"'
Autor:
Hitoshi Hayasaka, Hiroyuki Hanzawa, Takashi Asahi, Shin-ichi Katakura, Isao Yasumatsu, Kazuo Kanai, Osamu Ubukata, Sachiko Takaishi, Takahiro Kitamura, Yumi Matsui
Publikováno v:
Bioorganicmedicinal chemistry. 25(13)
Tumor cells switch glucose metabolism to aerobic glycolysis by expressing the pyruvate kinase M2 isoform (PKM2) in a low active form, providing glycolytic intermediates as building blocks for biosynthetic processes, and thereby supporting cell prolif
Publikováno v:
Applied Physics Express. 12:075504
Photoluminescence of Y2O3 is commonly activated by the doping of rare-earth elements such as Eu. In the present study, we produced undoped and 1 mol% Si4+-doped, polycrystalline Y2O3 phosphors emitting blue-light by employing flash-sintering process.
Autor:
Kazuyuki Tanabe, Yan-Lin Tao, Toshihiro Horii, Hitoshi Hayasaka, Hideo Tsukamoto, Katsuomi Watanabe, Xunjia Cheng, Hiroshi Tachibana, Jin-Ye Liu
Publikováno v:
Infection and Immunity
A combinatorial immunoglobulin gene library was constructed from peripheral blood lymphocytes of eight patients infected with Plasmodium falciparum and was screened for the production of human monoclonal antibody Fab fragments to the C-terminal 19-kD
Publikováno v:
FEBS letters. 279(2)
Effects of oligopeptides containing Lys residues on the conformation of poly(dG-m5dC) have been investigated by circular dichroism spectroscopy. Lys-Ala-Lys (KAK) and its longer analogs with Lys-Ala repeats are found to convert the B-form polynucleot
Publikováno v:
Applied Physics Express; 7/1/2019, Vol. 12 Issue 7, p1-1, 1p
Autor:
Chadwick, Derek J., Cardew, Gail
Publikováno v:
Oligonucleotides as Therapeutic Agents: Ciba Foundation Symposium 209; 2007, p124-141, 18p
Autor:
Michael Niaounakis
Biopolymers and biodegradable plastics are finding new applications in various sectors, from packaging, to medical, automotive and many more. As synthetic plastics are increasingly replaced by their bioplastic equivalents, engineers are facing new ch
Autor:
Derek J. Chadwick, Gail Cardew
The use of oligonucleotides as therapeutic agents rests upon their ability to interfere, in a sequence-specific manner, with the fundamental machinery of protein synthesis either by binding to the mRNAs transcribed from a gene or by binding directly